Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Clinical Chemistry
|
October 1, 1982
Interlaboratory surveys of the quantitation of thyroxin and thyrotropin (thyroid-stimulating hormone) in dried blood spot specimens
T L Hearn, W H Hannon
Annals of the New York Academy of Sciences
|
February 13, 1996
Multiple emulsions oral vaccine vehicles for inducing immunity or tolerance
T L Hearn, M Olsen, R L Hunter
Clinical Chemistry
|
February 1, 1985
Phenylalanine analyses of blood-spot control materials: preparation of samples and evaluation of interlaboratory performance
F W Spierto, T L Hearn, F H Gardner, et al.
Journal of Clinical Microbiology
|
August 1, 1990
Indirect immunofluorescence test performance and questionnaire results from the Centers for Disease Control Model Performance Evaluation Program for human immunodeficiency virus type 1 testing
R N Taylor, T L Hearn, W O Schalla, et al.
Archives of Pathology & Laboratory Medicine
|
July 11, 2000
Improvement in physician's office laboratory practices, 1989-1994
T M St John, H B Lipman, J M Krolak, et al.
Archives of Environmental Health
|
August 1, 1975
Smoking and disease: effect on serum antitrypsin in hospitalized patients
E D Rees, J W Hollingsworth, T R Hoffman, et al.
American Journal of Public Health
|
December 1, 1982
Laboratory evaluation and assistance efforts: mailed, on-site and blind proficiency testing surveys conducted by the Centers for Disease Control
D J Boone, H J Hansen, T L Hearn, et al.
JAMA
|
February 18, 1998
Variation in proficiency testing performance by testing site
T M Stull, T L Hearn, J S Hancock, et al.
Archives of Pathology & Laboratory Medicine
|
March 1, 1990
Centers for Disease Control perspective on quality assurance for human immunodeficiency virus type 1 antibody testing. Model Performance Evaluation Program
R O Valdiserri, R N Taylor, T L Hearn, et al.
American Journal of Public Health
|
April 1, 1991
Capacity of US labs to provide TLI in support of early HIV-1 intervention
R O Valdiserri, G D Cross, A R Gerber, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Clinical Chemistry
|
October 1, 1982
Interlaboratory surveys of the quantitation of thyroxin and thyrotropin (thyroid-stimulating hormone) in dried blood spot specimens
T L Hearn, W H Hannon
Annals of the New York Academy of Sciences
|
February 13, 1996
Multiple emulsions oral vaccine vehicles for inducing immunity or tolerance
T L Hearn, M Olsen, R L Hunter
Clinical Chemistry
|
February 1, 1985
Phenylalanine analyses of blood-spot control materials: preparation of samples and evaluation of interlaboratory performance
F W Spierto, T L Hearn, F H Gardner, et al.
Journal of Clinical Microbiology
|
August 1, 1990
Indirect immunofluorescence test performance and questionnaire results from the Centers for Disease Control Model Performance Evaluation Program for human immunodeficiency virus type 1 testing
R N Taylor, T L Hearn, W O Schalla, et al.
Archives of Pathology & Laboratory Medicine
|
July 11, 2000
Improvement in physician's office laboratory practices, 1989-1994
T M St John, H B Lipman, J M Krolak, et al.
Archives of Environmental Health
|
August 1, 1975
Smoking and disease: effect on serum antitrypsin in hospitalized patients
E D Rees, J W Hollingsworth, T R Hoffman, et al.
American Journal of Public Health
|
December 1, 1982
Laboratory evaluation and assistance efforts: mailed, on-site and blind proficiency testing surveys conducted by the Centers for Disease Control
D J Boone, H J Hansen, T L Hearn, et al.
JAMA
|
February 18, 1998
Variation in proficiency testing performance by testing site
T M Stull, T L Hearn, J S Hancock, et al.
Archives of Pathology & Laboratory Medicine
|
March 1, 1990
Centers for Disease Control perspective on quality assurance for human immunodeficiency virus type 1 antibody testing. Model Performance Evaluation Program
R O Valdiserri, R N Taylor, T L Hearn, et al.
American Journal of Public Health
|
April 1, 1991
Capacity of US labs to provide TLI in support of early HIV-1 intervention
R O Valdiserri, G D Cross, A R Gerber, et al.
Page
of 2